EMERGENCE OF ANTIRETROVIRAL DRUG RESISTANCE IN THERAPY-NAIVE HIV INFECTED PATIENTS IN HUNGARY

被引:5
|
作者
Juhasz, Emese [1 ]
Ghidan, A. [1 ]
Kemeny, B. [2 ]
Nagy, K. [1 ]
机构
[1] Semmelweis Univ, Inst Med Microbiol, Budapest, Hungary
[2] Natl Inst Dermatovenerol, Budapest, Hungary
关键词
genotyping; HIV-1 drug resistant mutants; therapy-naive HIV-infected patients; nucleoside analogue reverse transciptase inhibitors;
D O I
10.1556/AMicr.55.2008.4.3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mutations in the HIV-1 genes associated with resistance to antiretroviral drugs were detected also in primary HIV infected individuals who did not receive antiretroviral treatment. Drug resistance genotyping of HIV pol gene was done by in situ DNA hybridization using a Line Probe Assay and by direct sequencing. Viral variants harbouring resistance mutations such as: M41, T69R, K70R, M184V, T215Y in the pol gene were detected in 14% of the subjects. HIV mutants resistant to NRT inhibitors were found in 10 and 20% of patients infected before and after the year 2000, respectively. Multiple drug resistant viruses (2-3 drug classes) were present in 3.5% of the mainly recently infected patients. In protease gene only minor resistant mutations were found such as L10I and A71V. These findings indicate the evolution of drug resistance showing a correlation with the time of introduction of combination therapy in our country, where more than 70% of HIV infections were by homo/bisexual transmission. This confirms the transmission of drug-resistant HIV shown by genotype testing during primary infection in therapy-naive patients and initiates serious clinical and public health consequences.
引用
收藏
页码:383 / 394
页数:12
相关论文
共 50 条
  • [21] Performance of the VERSANT® HIV-1 Resistance Assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes
    Derdelinckx, I
    Van Laethem, K
    Maes, B
    Schrooten, Y
    De Schouwer, K
    De Wit, S
    Fransen, K
    Ribas, SG
    Moutschen, M
    Vaira, D
    Zissis, G
    Van Ranst, M
    Van Wijngaerden, E
    Vandamme, AM
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2003, 39 (02): : 119 - 124
  • [22] GW433908/ritonavir once daily in antiretroviral therapy-naive HIV-infected patients: absence of protease resistance at 48 weeks
    MacManus, S
    Yates, PJ
    Elston, RC
    White, S
    Richards, N
    Snowden, W
    AIDS, 2004, 18 (04) : 651 - 655
  • [23] Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients
    Nanfack, Aubin J.
    Redd, Andrew D.
    Bimela, Jude S.
    Ncham, Genesis
    Achem, Emmanuel
    Banin, Andrew N.
    Kirkpatrick, Allison R.
    Porcella, Stephen F.
    Agyingi, Lucy A.
    Meli, Josephine
    Colizzi, Vittorio
    Nadas, Arthur
    Gorny, Miroslaw K.
    Nyambi, Phillipe N.
    Quinn, Thomas C.
    Duerr, Ralf
    JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (09) : 2785 - 2800
  • [24] Fosamprenavir - A review of its use in the management of antiretroviral therapy-naive patients with HIV infection
    Chapman, TM
    Plosker, GL
    Perry, CM
    DRUGS, 2004, 64 (18) : 2101 - 2124
  • [25] FosamprenavirA Review of its Use in the Management of Antiretroviral Therapy-Naive Patients with HIV Infection
    Therese M. Chapman
    Greg L. Plosker
    Caroline M. Perry
    Drugs, 2004, 64 : 2101 - 2124
  • [26] Evaluating the use of procalcitonin in an asymptomatic, HIV-infected antiretroviral therapy-naive, South African cohort
    Phatlhane, Dineo V.
    Ipp, Hayley
    Erasmus, Rajiv T.
    Zemlin, Annalise E.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (03) : 501 - 508
  • [27] The Influence of Social Networks on Antiretroviral Therapy Initiation Among HIV-Infected Antiretroviral Therapy-Naive Youth in Rural Kenya and Uganda
    Brown, Lillian B.
    Balzer, Laura B.
    Kabami, Jane
    Kwarisiima, Dalsone
    Sang, Norton
    Ayieko, James
    Chen, Yiqun
    Chamie, Gabriel
    Charlebois, Edwin D.
    Camlin, Carol S.
    Cohen, Craig R.
    Bukusi, Elizabeth
    Kamya, Moses R.
    Moody, James
    Havlir, Diane V.
    Petersen, Maya L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 83 (01) : 9 - 15
  • [28] Response to Therapy in Antiretroviral Therapy-Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor-Associated Transmitted Drug Resistance
    Clutter, Dana S.
    Fessel, W. Jeffrey
    Rhee, Soo-Yon
    Hurley, Leo B.
    Klein, Daniel B.
    Ioannidis, John P. A.
    Silverberg, Michael J.
    Shafer, Robert W.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 (02) : 171 - 176
  • [29] Prevalence of Transmitted HIV Drug Resistance Among Newly Diagnosed Antiretroviral Therapy-Naive Pregnant Women in Lilongwe and Blantyre, Malawi
    Wadonda-Kabondo, Nellie
    Banda, Richard
    Moyo, Kundai
    M'bang'ombe, Maurice
    Chiwaula, Mabvuto
    Porter, Carol
    Jordan, Michael R.
    CLINICAL INFECTIOUS DISEASES, 2012, 54 : S324 - S327
  • [30] HIV Drug Resistance and Its Impact on Antiretroviral Therapy in Chinese HIV-Infected Patients
    Xing, Hui
    Ruan, Yuhua
    Li, Jingyun
    Shang, Hong
    Zhong, Ping
    Wang, Xia
    Liao, Lingjie
    Li, Hanping
    Zhang, Min
    Xue, Yile
    Wang, Zhe
    Su, Bin
    Liu, Wei
    Dong, Yonghui
    Ma, Yanling
    Li, Huiqin
    Qin, Guangming
    Chen, Lin
    Pan, Xiaohong
    Chen, Xi
    Peng, Guoping
    Fu, Jihua
    Chen, Ray Y.
    Kang, Laiyi
    Shao, Yiming
    PLOS ONE, 2013, 8 (02):